This topic contains a solution. Click here to go to the answer
« previous next »

Author Question: A pregnant patient is taking an atypical antipsychotic. For what specific risk should the nurse ... (Read 34 times)

Melani1276

  • Hero Member
  • *****
  • Posts: 516
on: Jul 19, 2018
A pregnant patient is taking an atypical antipsychotic. For what specific risk should the nurse monitor this patient?
 
  1. Depression
  2. Preeclampsia
  3. Hypothyroidism
  4. Gestational diabetes

Question 2

A patient diagnosed with depression tells the nurse that, on the advice of her friends, she discontinued her medication as soon as she discovered she was pregnant. What is the most appropriate way for the nurse to respond?
 
  1. That is a good idea. Those drugs can be dangerous.
  2. It is never a good idea to stop taking antidepressant medication.
  3. If you don't continue to take the medication, you are seriously endangering yourself.
  4. I think you should consult with your prescribing provider and get all the information you need to help you make the best decision.


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

katkat_flores

  • Sr. Member
  • ****
  • Posts: 328
Reply #1 on: Jul 19, 2018
Answer to Question 1

Answer: 4
Explanation: Many atypical antipsychotics can induce metabolic syndrome, increasing the risk for gestational diabetes in the mother, which increases the overall pregnancy risk and requires close monitoring throughout the pregnancy. Depression risk, the risk of preeclampsia, and the possibility of hypothyroidism are not increased in pregnant patients taking atypical antipsychotics.

Answer to Question 2

Answer: 4
Explanation: A comprehensive risk-benefit analysis for both the mother and the fetus should be performed with the patient's provider and the patient's decision should be supported by the nursing staff. Although antidepressant medications taken during pregnancy may have adverse consequences, discontinuation of treatment during pregnancy has been shown to increase rates of relapse, and untreated or inadequately treated depression or anxiety can have a negative impact on the neurodevelopment of the fetus. The decision to discontinue medication should be made using a risk-benefit analysis in consultation with the prescribing provider.


Melani1276

  • Member
  • Posts: 516
Reply 2 on: Jul 19, 2018
:D TYSM

at

  • Member
  • Posts: 359
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

« previous next »
 

Did you know?

In 1844, Charles Goodyear obtained the first patent for a rubber condom.

Did you know?

The FDA recognizes 118 routes of administration.

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Did you know?

The human body produces and destroys 15 million blood cells every second.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Many hobbies and leisure activities have some risk of health-related injuries Many hobbies and leisure activities have some risk of health-related injuries
Photograph of an occupational therapist assisting a patient with learning independence in activities Photograph of an occupational therapist assisting a patient with learning independence in activities
Patient Teaching Patient Teaching
Nursing care plan - risk for infection Nursing care plan - risk for infection
Helping maintain accurate patient records is a critical part of the medical assistant's work. Helping maintain accurate patient records is a critical part of the medical assistant's work.
Instructing the Patient in Collecting a Stool Specimen Instructing the Patient in Collecting a Stool Specimen
Video: Second Messengers in the Inositol-lipid Signaling Pathway

For a complete list of videos, visit our video library